As described by Walter et al. [36], MR-ProADM and NT-proBNP were valuable predictive markers for mortality risk in acute myocardial infarction as well as in other long-term adverse clinical outcomes including recurrent acute myocardial infarction, congestive heart failure, cardiopulmonary resuscitation and cardiogenic shock or syncope. This evidence concerns the gene NPPB and myocardial infarction.